The Josep Carreras Institute, a CERCA center of the Generalitat de Catalunya for the scientific excellence, has as one of its main objectives the promotion of translational biomedical research and the development of personalized medicine in malignant hematological diseases, particularly of leukemia. The center, founded jointly in 2010 by the Josep Carreras Foundation and the Generalitat de Catalunya, hosts researchers from all around the world aiming to improve the living conditions of patients and, some day, achieve a definitive cure for leukemia and other hematological diseases. It is one of the few research centers in the world exclusively focused on leukemia.

On the other hand, the Catalan Scientific Communication Association (ACCC) has a history of more than 30 years in the field of scientific communication, dissemination, and science journalism, devoted to influencing the social and political aspects of scientific information, while ensuring it contributes to social progress. The association facilitates the continuous training of its members, as well as encouraging debate and self-criticism among them.

Given the commitment of the Josep Carreras Leukemia Research Institute to promote research, biomedical innovation, and scientific dissemination, both entities have agreed to strengthen their ties and join the Institute as one of the ACCC collaborating entities, together with BIST, Ciment Català, Fundació AGBAR, Fundació BBVA, Fundació Catalana per la Recerca i la Innovació and Fundació “la Caixa”.

ACCC collaborating entities are institutions and companies that contribute to the maintenance of the Association, giving it corporate and financial support through annual contributions set by the Board of Directors. In return, these entities receive several advantages, such as technical advice on scientific communication tasks, support in finding professionals in the field, being listed as collaborators in our online channels and access to dissemination materials, communication, and outreach projects. They will have priority when organizing events or requesting projects together with the association or our working groups, spreading their messages through our channels, such as the distribution list, which includes more than 550 professionals, and may attend the General Assembly with a voice.

We are convinced that this collaboration agreement will bear fruit soon and will help to spread the latest developments in the fight against leukemia to the public, contributing to a freer, healthier and more confident society.